Proposal for new USP Chapter <319> on NMR Block Length Determination
Recommendation
20/21 October 2026
Performance Evaluation and Monitoring for compliant Analytical Procedures and Processes
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
In Pharmacopeial Forum 52(1), a new USP General Chapter, <319> Nuclear Magnetic Resonance Spectroscopy Block Length Determination for Lactide–Glycolide Polymers has been published for comment..
At the end of October 2025, USP had already published a general chapter prospectus outlining the background and rationale for the development of this chapter.
The proposal notes that “block length is a critical property for understanding and controlling the composition and variability of excipients during formulation development, manufacturing, and testing of lactide–glycolide and lactic acid–glycolic acid polymers (PLGs and PLGAs).” The chapter describes a 13C nuclear magnetic resonance (13C-NMR) method to determine the glycolate block length in lactide–glycolide polymers that are ring-opening copolymers of DL-lactide and glycolide.
The proposal is available free of charge on the Pharmacopeial Forum website, and comments can be submitted until 31 May 2026.
Related GMP News
07.10.2026Analytical Quality Group Developments May through August 2026
07.10.2026Two New FDA Warning Letters Put OOS Investigations in Focus
07.10.2026Pharmeuropa: Revision Proposed for Chapter 2.5.32 on Coulometric Karl Fischer Water Determination
30.09.2026The Relationship between the BP and the Ph. Eur.
30.09.2026New Japanese Pharmacopoeia Drafts (September 2026) Open for Public Comment
30.09.2026EMA publishes final ICH M13B Guideline and Q&A on Bioequivalence